Paris, France

Fréderic Bailly


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fréderic Bailly: Innovator in Chemical Synthesis

Introduction

Fréderic Bailly is a notable inventor based in Paris, France. He has made significant contributions to the field of chemical synthesis, particularly in the preparation of specialized compounds. His work has implications in various applications, showcasing the importance of innovation in chemistry.

Latest Patents

Fréderic Bailly holds a patent for a method for preparing 3-keto-benzofurane derivatives. This invention relates to a method for synthesizing 3-keto-benzofurane derivatives of the general formula: Formula (I), where R is an alkyl or aryl group, and R is hydrogen or an alkyl or aryl group. The preparation method involves coupling a derivative of Formula III, where X is chlorine, bromine, or iodine or a sulfonate grouping, with a sulfonamide derivative of the formula R—SO—NH in the presence of a basic agent and a catalytic system formed of a complex between a palladium compound and a ligand. This patent highlights his innovative approach to chemical synthesis.

Career Highlights

Fréderic Bailly is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to contribute to advancements in pharmaceutical chemistry. His expertise in chemical synthesis has positioned him as a valuable asset in the research and development sector.

Collaborations

Throughout his career, Fréderic has collaborated with esteemed colleagues such as Thomas Priem and Philippe Vayron. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Fréderic Bailly's contributions to the field of chemical synthesis exemplify the impact of innovation in science. His patent for the preparation of 3-keto-benzofurane derivatives showcases his commitment to advancing chemical methodologies. Through his work at Sanofi and collaborations with fellow researchers, he continues to influence the landscape of pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…